These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 34345304)
1. NRF-1 directly regulates TFE3 and promotes the proliferation of renal cancer cells. Zhuang W; Dong X; Wang B; Liu N; Guo H; Zhang C; Gan W Oncol Lett; 2021 Sep; 22(3):679. PubMed ID: 34345304 [TBL] [Abstract][Full Text] [Related]
2. TFE3 regulates renal adenocarcinoma cell proliferation via activation of the mTOR pathway. Fang Y; Bao W; Rao Q; Wang X; Xia Q; Shen Q; Zhou X; Yao B Mol Med Rep; 2017 Sep; 16(3):2721-2725. PubMed ID: 28713889 [TBL] [Abstract][Full Text] [Related]
3. TFE3 fusions escape from controlling of mTOR signaling pathway and accumulate in the nucleus promoting genes expression in Xp11.2 translocation renal cell carcinomas. Yin X; Wang B; Gan W; Zhuang W; Xiang Z; Han X; Li D J Exp Clin Cancer Res; 2019 Mar; 38(1):119. PubMed ID: 30849994 [TBL] [Abstract][Full Text] [Related]
4. ASPSCR1::TFE3-mediated upregulation of insulin receptor substrate 2 (IRS-2) activates PI3K/AKT signaling and promotes malignant phenotype. Ishiguro N; Nakagawa M Int J Biochem Cell Biol; 2024 Nov; 176():106676. PubMed ID: 39419345 [TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma. Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289 [TBL] [Abstract][Full Text] [Related]
6. Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion. Kauffman EC; Lang M; Rais-Bahrami S; Gupta GN; Wei D; Yang Y; Sourbier C; Srinivasan R BMC Cancer; 2019 Sep; 19(1):917. PubMed ID: 31519159 [TBL] [Abstract][Full Text] [Related]
7. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway. Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766 [TBL] [Abstract][Full Text] [Related]
8. Renal carcinoma-associated transcription factors TFE3 and TFEB are leukemia inhibitory factor-responsive transcription activators of E-cadherin. Huan C; Sashital D; Hailemariam T; Kelly ML; Roman CA J Biol Chem; 2005 Aug; 280(34):30225-35. PubMed ID: 15994295 [TBL] [Abstract][Full Text] [Related]
12. CARM1 promotes gastric cancer progression by regulating TFE3 mediated autophagy enhancement through the cytoplasmic AMPK-mTOR and nuclear AMPK-CARM1-TFE3 signaling pathways. Yang S; Zhang J; Chen D; Cao J; Zheng Y; Han Y; Jin Y; Wang S; Wang T; Ma L; Luo T; Wang Y; Qin W; Dong L Cancer Cell Int; 2022 Mar; 22(1):102. PubMed ID: 35246137 [TBL] [Abstract][Full Text] [Related]
13. Elucidation of the therapeutic role of mitochondrial biogenesis transducers NRF-1 in the regulation of renal fibrosis. Hsieh PF; Liu SF; Hung TJ; Hung CY; Liu GZ; Chuang LY; Chen MF; Wang JL; Shi MD; Hsu CH; Shiue YL; Yang YL Exp Cell Res; 2016 Nov; 349(1):23-31. PubMed ID: 27634749 [TBL] [Abstract][Full Text] [Related]
14. TFE3 transcription factor regulates the expression of MAFB during macrophage differentiation. Zanocco-Marani T; Vignudelli T; Parenti S; Gemelli C; Condorelli F; Martello A; Selmi T; Grande A; Ferrari S Exp Cell Res; 2009 Jul; 315(11):1798-808. PubMed ID: 19332055 [TBL] [Abstract][Full Text] [Related]
15. RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review. Kato I; Furuya M; Baba M; Kameda Y; Yasuda M; Nishimoto K; Oyama M; Yamasaki T; Ogawa O; Niino H; Nakaigawa N; Yano Y; Sakamoto K; Urata Y; Mikami K; Yamasaki S; Tanaka R; Takagi T; Kondo T; Nagashima Y Histopathology; 2019 Aug; 75(2):254-265. PubMed ID: 30908700 [TBL] [Abstract][Full Text] [Related]
16. TFE3 inhibits myoblast differentiation in C2C12 cells via down-regulating gene expression of myogenin. Naka A; Iida KT; Nakagawa Y; Iwasaki H; Takeuchi Y; Satoh A; Matsuzaka T; Ishii KA; Kobayashi K; Yatoh S; Shimada M; Yahagi N; Suzuki H; Sone H; Yamada N; Shimano H Biochem Biophys Res Commun; 2013 Jan; 430(2):664-9. PubMed ID: 23211595 [TBL] [Abstract][Full Text] [Related]
17. ASPL-TFE3 Oncoprotein Regulates Cell Cycle Progression and Induces Cellular Senescence by Up-Regulating p21. Ishiguro N; Yoshida H Neoplasia; 2016 Oct; 18(10):626-635. PubMed ID: 27673450 [TBL] [Abstract][Full Text] [Related]
18. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422 [TBL] [Abstract][Full Text] [Related]
19. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway. Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529 [TBL] [Abstract][Full Text] [Related]
20. Transcription Factor Tfe3 Directly Regulates Pgc-1alpha in Muscle. Salma N; Song JS; Arany Z; Fisher DE J Cell Physiol; 2015 Oct; 230(10):2330-6. PubMed ID: 25736533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]